Low Field Magnetic Stimulation Ameliorates Schizophrenia-Like Behavior and Up-Regulates Neuregulin-1 Expression in a Mouse Model of Cuprizone-Induced Demyelination
Open Access
- 6 December 2018
- journal article
- research article
- Published by Frontiers Media SA in American Journal of Translational Research
- Vol. 9, 675
- https://doi.org/10.3389/fpsyt.2018.00675
Abstract
White matter and myelin sheath integrity are disrupted in schizophrenia, and non-invasive magnetic brain stimulation targeting these tracts is a promising new therapeutic approach. In particular, deep-brain reachable low field magnetic stimulation (DMS) could alleviate cognitive impairment and depressive-like behaviors in animal models. In this study, we sought to assess the effects of DMS on myelin sheath damage and schizophrenia-like behaviors in the cuprizone-induced demyelination mouse model. Mice were fed cuprizone (copper ion chelating agent, 0.2% w/w mixed with food) for 6 weeks to induce demyelination. During these 6 weeks, mice were stimulated with either sham, low-frequency (LFS, delta frequency) DMS or high-frequency (HFS, gamma Hz) DMS for 20 min each day. Behavioral tests were conducted 24 h after the final DMS session. The myelin sheath was examined by immunohistochemistry and the expression of neuregulin-1 (NRG1)/ErbB4 in the prefrontal cortex was measured with Western blotting. Six weeks of HFS significantly alleviated schizophrenia-like behaviors in cuprizone mice, including improved nesting, social interaction and sensorimotor gating, while LFS improved sensorimotor gating only. HFS and LFS both repaired the myelin sheath and increased the expression of neuregulin-1 and its receptor ErbB4, in the prefrontal cortex of demyelinated mice. Our findings show that DMS is a potential effective neuromodulation technique for the treatment of schizophrenia. One possible mechanism underlying these therapeutic effects could involve the up-regulation of NRG1/ErbB4 signaling in the prefrontal cortex.Keywords
Funding Information
- Beijing Municipal Natural Science Foundation (7164264)
- National Natural Science Foundation of China (81601185, 81471378, 81801339)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201607)
This publication has 58 references indexed in Scilit:
- Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factorCNS Spectrums, 2019
- Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's diseaseAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2017
- Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in DepressionBiological Psychiatry, 2014
- Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in SchizophreniaBrain Stimulation, 2014
- Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analysesAnnals of Medicine, 2013
- Rethinking schizophreniaNature, 2010
- Mental health in the tropicsPathogens and Global Health, 2009
- Low-Field Magnetic Stimulation in Bipolar Depression Using an MRI-Based StimulatorAmerican Journal of Psychiatry, 2004
- SchizophreniaThe New England Journal of Medicine, 2003
- Symptoms, signs, and diagnosis of schizophreniaThe Lancet, 1995